Target intelligence / Profile preview

Integrin alpha5beta1 (ITGA5:ITGB1)

Target
ITGA5:ITGB1
Molecular classification
Receptor, Integrin
01

Overview

Integrin alpha5beta1 is a major cellular receptor for fibronectin, playing a crucial role in cell adhesion, migration, and signaling. It mediates bidirectional signaling across the cell membrane, influencing cell behavior and fate. Overexpression of integrin alpha5beta1 is associated with aggressive cancer types, making it a therapeutic target for cancer treatment.

Other names
Fibronectin receptor
02

Mechanism of action

Integrin alpha5beta1 inhibitors block the interaction between the integrin and its ligands, such as fibronectin, thereby disrupting cell adhesion, migration, and signaling pathways involved in tumor growth and metastasis.

03

Biological functions

Cell adhesionCell migrationSignal transductionECM assembly
04

Disease associations

CancerTumor progressionMetastasis
05

Safety considerations

Potential for off-target effects due to RGD sequence promiscuityPossible disruption of normal cell adhesion and tissue homeostasis
06

Biomarkers

Integrin alpha5beta1 expression levels in tumor tissueSoluble fibronectin levels

Beyond the preview

Go deeper on Integrin alpha5beta1 (ITGA5:ITGB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrin alpha5beta1 (ITGA5:ITGB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call